Intellego Technologies AB Stock

Equities

INT

SE0016075063

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm 11:29:51 2024-05-20 EDT 5-day change 1st Jan Change
27.25 SEK -0.37% Intraday chart for Intellego Technologies AB -6.03% +61.24%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2021 9.51M 890K 1.21M Sales 2022 59.22M 5.54M 7.55M Capitalization 239M 22.38M 30.51M
Net income 2021 -3M -281K -383K Net income 2022 -9M -842K -1.15M EV / Sales 2021 35 x
Net cash position 2021 8.24M 771K 1.05M Net cash position 2022 24.21M 2.27M 3.09M EV / Sales 2022 3.63 x
P/E ratio 2021
-86.1 x
P/E ratio 2022
-22.8 x
Employees 62
Yield 2021 *
-
Yield 2022
-
Free-Float 94.77%
More Fundamentals * Assessed data
Dynamic Chart
Sweden's Intellego Technologies Names CFO MT
Intellego Technologies AB Appoints Petra Olofsson as Chief Financial Officer CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Intellego Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Intellego Technologies Obtains Up to SEK40 Million Credit Line Ahead of New Product Launches MT
Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Intellego Technologies AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Certain Shares of Intellego Technologies AB are subject to a Lock-Up Agreement Ending on 24-DEC-2022. CI
Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Intellego Technologies AB (OM:INT) agreed to acquire Daro Group Limited for ú10 million. CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Intellego Technologies AB (OM:INT) signed letter of intent to acquire majority stake in Jiangyin Feiyang Instrument Co., Ltd CI
More news
1 day-0.37%
1 week-6.03%
Current month-7.00%
1 month+4.01%
3 months+58.43%
6 months+86.90%
Current year+61.24%
More quotes
1 week
25.90
Extreme 25.9
28.65
1 month
25.30
Extreme 25.3
32.50
Current year
13.44
Extreme 13.44
32.50
1 year
9.80
Extreme 9.8
34.50
3 years
4.00
Extreme 4
34.50
5 years
4.00
Extreme 4
34.50
10 years
4.00
Extreme 4
34.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 11-08-30
Sales & Marketing - 20-12-31
Sales & Marketing - 21-01-31
Members of the board TitleAgeSince
Chairman 67 -
Director/Board Member 77 16-12-31
Director/Board Member - -
More insiders
Date Price Change Volume
24-05-20 27.25 -0.37% 221,333
24-05-17 27.35 +4.19% 91,800
24-05-16 26.25 -5.91% 212,852
24-05-15 27.9 +0.36% 222,544
24-05-14 27.8 -4.14% 163,538

Delayed Quote Nasdaq Stockholm, May 20, 2024 at 11:29 am

More quotes
Intellego Technologies AB is a Sweden-based company engaged in photochromatic indicator technology. The Company is a manufacturer of colorimetric ultraviolet indicators. UVC Dosimeters are used in Healthcare, Hospitality, Retail, Transportation and Commercial Applications around the world. With its patented photochromic ink that changes color based on exposure to ultraviolet irradiation or specific substances, Intellego produces dosimeters in a variety of formats and custom options to meet the constantly evolving needs of Ultraviolet Device Manufacturers (OEMs) and end-users. Intellego Technologies is headquartered in Stockholm, with product development and manufacturing based in the southwest region of Sweden.
Calendar
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW